Evotec SE (EVO)
5.25
-0.24
(-4.37%)
USD |
NASDAQ |
May 17, 16:00
5.26
+0.01
(+0.19%)
After-Hours: 20:00
Evotec Shareholders Equity (Quarterly): 1.238B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.238B |
September 30, 2023 | 1.208B |
June 30, 2023 | 1.276B |
December 31, 2022 | 1.273B |
September 30, 2022 | 1.208B |
June 30, 2022 | 1.332B |
March 31, 2022 | 1.462B |
December 31, 2021 | 1.560B |
September 30, 2021 | 1.151B |
June 30, 2021 | 1.015B |
March 31, 2021 | 929.68M |
December 31, 2020 | 891.05M |
September 30, 2020 | 555.06M |
June 30, 2020 | 535.43M |
March 31, 2020 | 539.86M |
December 31, 2019 | 534.35M |
September 30, 2019 | 505.24M |
June 30, 2019 | 498.30M |
March 31, 2019 | 502.42M |
December 31, 2018 | 485.02M |
September 30, 2018 | 452.46M |
June 30, 2018 | 407.07M |
March 31, 2018 | 417.08M |
December 31, 2017 | 397.01M |
September 30, 2017 | 373.78M |
Date | Value |
---|---|
June 30, 2017 | 358.28M |
March 31, 2017 | 333.69M |
December 31, 2016 | 225.21M |
September 30, 2016 | 216.50M |
June 30, 2016 | 206.29M |
March 31, 2016 | 205.69M |
December 31, 2015 | 202.81M |
September 30, 2015 | 199.59M |
June 30, 2015 | 202.50M |
March 31, 2015 | 176.87M |
December 31, 2014 | 192.60M |
September 30, 2014 | 197.47M |
June 30, 2014 | 214.08M |
March 31, 2014 | 214.50M |
December 31, 2013 | 219.51M |
September 30, 2013 | 239.78M |
June 30, 2013 | 191.19M |
March 31, 2013 | 191.50M |
December 31, 2012 | 201.74M |
September 30, 2012 | 204.55M |
June 30, 2012 | 188.33M |
March 31, 2012 | 193.32M |
December 31, 2011 | 190.73M |
September 30, 2011 | 202.14M |
June 30, 2011 | 200.06M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
498.30M
Minimum
Jun 2019
1.560B
Maximum
Dec 2021
983.97M
Average
1.083B
Median
Shareholders Equity (Quarterly) Benchmarks
Centogene NV | -27.95M |
Affimed NV | 63.90M |
InflaRx NV | 102.33M |
MorphoSys AG | 54.22M |
BioNTech SE | 21.56B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.490B |
Total Liabilities (Quarterly) | 1.252B |
Debt to Equity Ratio | 0.5592 |
Current Ratio | 1.944 |
Net Debt Paydown Yield | -1.69% |